ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Civil Rights Groups and Communalism

Saheli, Chingari, three women's organisations in Hyderabad, Delhi and Ahmedabad respectively, concerned doctors (Shyama Narang, Kamala Jayarao, Pevayani Dangoria, A K Vasudevan, Ramana Dhara) and journalist (Vimal Balasubrahmanyan), The Court today (May 1, 1986) issued notice to the respondents to show cause as to why the petition should not be admitted and stay order granted on further trials of the contraceptive. In addilion to the Health Ministry, the ICMR, and the State of Andhra Pradesh, the Drug Controller of India was also impleaded as a respondent. The notice is returnable on July 15, 1986 The contraceptive in question is Norethi- sterone-Oenanthate (Net-Oen), an injectable form of the female hormone, progesterone, similar to the controversial drug Depo- Provera. Produced by Schering, a West German firm it was first marketed in Peru in 1967. In 1971, it was withdrawn as rats tested with this drug developed pituitary and breast nodules. Thereafter, it was put back on the market and is now being propagated as the ideal contraceptive for third world women.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top